Reuters: Global Markets: Ablynx shares hit one-year high after Merck deal

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Ablynx shares hit one-year high after Merck deal Oct 2nd 2012, 07:11 BRUSSELS | Tue Oct 2, 2012 3:11am EDT BRUSSELS (Reuters) - Shares in Ablynx (ABLX.BR) hit a new one-year high after the Belgian drug developer announces it is entering into a potentially lucrative partnership with Merck & Co (MRK.N). The shares rise as much as 4.1 percent in early trading to 4.80 euros.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions